Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2002-12-10
2004-01-13
Solola, Taofiq (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S349000
Reexamination Certificate
active
06677463
ABSTRACT:
FIELD OF INVENTION
The present invention relates to a single pot process for preparing artesunic acid from artemisinin. Artesunic acid is the 10 &agr;-hemisuccinate ester of dihydroartemisinin. Artesunic acid and artesunate are customary names for dihydroartemisinin hemisuccinate and its sodium salt, respectively.
BACKGROUND OF THE INVENTION
Malaria is caused by protozoan parasites, notably
Plasmodium falciparum.
The range of drugs available in the market for prevention and treatment of malaria is limited, and there are problems of drug resistance. Artemisinin and its derivatives: artemether and arteether (oil soluble), artelinate and artesunate (water soluble), are a class of anti-malarial compounds derived from
Artemisia annua
which are now proving their promising activity and are being used for the treatment of uncomplicated/severe complicated/cerebral and multi drug resistant malaria. The chemistry and the anti-protozoal action of these compounds, described in the publications are listed as references cited.
The water-insoluble artesunic acid is customarily administered orally in the form of tablets or rectally in the for mn of suppositories, while the water-soluble artesunate is administered intravenously.
Artesunic acid together with a number of other C
10
-ester and C
10
-ether derivatives of dihydroartemisinin, were prepared for the first time by Chinese scientists at the end of 1979 to the beginning of 1980. Shaofeng et al., H Labeling of QHS Derivatives, Bull. Chin. Materia Medica 6 (4), 25-27 (1981) and Li et al., Synthesis of Ethers. Carboxylic esters and carbonates of Dihydroartemisinin, Acta Pharm. Sin 16(6), 429-39, 1981) describe the preparation of artesunic acid by acylation of dihydroartemisinin with succinic anhydride in pyridine. The above mentioned publications describe a general method for preparing various dihydroartemisinin C
10
-esters and also provide a process for preparing artesunic acid in a yield of 60% by means of warming dihydroartemisinin and succinic anhydride in pyridine at 30° C. for 24 hours.
Ying et al. in the Synthesis of some carboxylic esters and carbonates of Dihydroartemisinin by using 4-(N,N-Dimethylamino)pyridine as an active acylation catalyst, Acta Chim Sinica 40 (6), 557-561 982) proposed an improved version of the acylation of dihydroartemisinin. The said publication described in detail with the aid of the preparation of dihydroartemisinin—10-valerate the aforesaid process. In this process dihydroartimisinin was dissolved in 1,2-dichloroethane and treated with valeric anhydride, 4-(N,N-dimethylamino)pyridine and triethylamine, and the mixture was stirred at room temperature until dihydroartemisinin had been used up. The reaction mixture was then acidified with dilute hydrochloric acid and the aqueous phase was separated off. The oily residue, obtained after washing and drying the organic phase and distilling off the solvent, was purified by chromatography on silica gel using petroleum ether 60-80° C. degree/ethyl acetate (10:1) as an eluent. The use of this procedure for the preparation of the artesunic acid from dihydroartemisinin with succinic anhydride and 4-(N,N-dimethylamino)pyridine afforded artesunic acid in a yield of 65% in 5 hours. U.S. Pat. No. 5,654,446 granted to Ognyanov et al. titled “Process for preparation of Dihydroartemisinin Hemisuccinate (artesunic acid)”, dated Aug. 5, 1997 teaches a process for preparing C
10
&agr;-artesunic acid by acylation of dihydroartemisinin with succinic anhydride, in the presence of trialkylamines and their mixture in a low boiling, neutral water miscible, inert organic solvent or solvent mixture at 20-60° C. in 0.5 hours and the artesunic acid is then isolated directly at pH 5 to 8 in 91.8 to 97.2% yield.
The above mentioned methods carry some disadvantages being less cost effective and more time consuming as compared to the present invention it should be noted that all the above referenced methods require two separate steps to convert artemisinin into 10-esters of dihydroartemisinin i.e. (a) reduction of artemisinin into dihydroartemisinin in the first pot following by isolation of dihydroartemisinin, and (b) esterification of dihydroartemisinin into different esters in the second pot.
Further, solvent pyridine or 1,2 dichloroethane and catalyst, 4(N,N-dimethylamino)pyridine used in these processes are not acceptable according to the health standard. Hence there is a need to provide a single step process that overcomes the above-mentioned disadvantages.
The present is able to overcome the shortcoming of the cited prior art processes being one pot conversion using artemisinin directly (rather than dihydroartemisinin as in above citations), using the process described at room temperature.
OBJECTS OF THE INVENTION
The main object of the present invention is to provide a single pot process for conversion of artemisinin to artesunic acid.
Another object of the present invention is to provide a process wherein reduction and esterification of artemisinin to obtain artesunic acid is carried out in a single pot.
Yet another object of the present invention is to provide a process wherein conversion of artemisinin to artesunic acid is carried out at room temperature.
SUMMARY OF THE INVENTION
Accordingly, the present invention provides a single pot process for the preparation of artesunic acid from artemisinin involving reduction followed by esterification of the reduced product at room temperature.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides a single pot process for preparing artesunic acid from artemisinin the said process comprising the steps of:
(a) dissolving artemisinin in a solvent at a temperature ranging between 20 to 35° C. to obtain a solution, adding a catalyst to the solution;
(b) adding a reducing agent to step (a) solution, stirring the mixture at a temperature ranging between 20 to 35° C. for about 0.5 h to 4 h to obtain the reduced product dihydroartemisinin;
(c) adding succinic anhydride and a base to the mixture of step (b) at a temperature ranging between 20 to 35° C.;
(d) stirring the mixture of step (c) at a temperature ranging between 20 to 35° C. for a time period of 1 h to 3 h;
(e) adding cold water to the mixture of step (d), adjusting the pH of the solution between 5 to 7, extracting the solution of pH 5 to 7 with a mixture of ethyl acetate and n-hexane, separating the organic layer;
(f) washing the organic layer of step (e) with water, drying the washed organic layer over anhydrous sodium sulphate, filtering, evaporating the organic layer to obtain a residue, and (g) purifying the residue of step (f) over silica gel column chromatography to obtain pure artesunic acid.
In an embodiment of the present invention, the two reactions, namely reduction of artemisinin to dihydroartemisinin and esterification of dihydroartemisinin are carried out in a single pot thereby avoiding the process of isolation of the intermediate dihydroartemisinin.
In another embodiment of the present invention, the solvent used in step (a) is selected from the group consisting of 1,4-dioxan or tetrahydrofuran.
In yet another embodiment of the present invention, the catalyst used in step (a) is selected from the group consisting of polyhydroxy compound or a cation exchange resin.
In still another embodiment of the present invention, the polyhydroxy compound used is dextrose.
In a further embodiment of the present invention, the w/w ratio of artemisinin and the catalyst is in the range of 1:2 to 1:5.
In one more embodiment of the present invention, the reducing agent used in step (b) is selected from the group consisting of sodium borohydride, lithium aluminium hydride, lithium tritertbutoxy aluminium gydride, lithium trimethoxy aluminium hydride, sodium trimethoxy borohydride, sodium bis-2-methoxy, ethoxy aluminium hydride or a mixture of lithium or sodium in alcohol or liquid ammonia.
In one another embodiment of the present invention, the reducing agent used is sodium borohydride.
In an embodiment of the present invention, the w/w ratio of artemisinin and sodium
Bhakuni Rajendra Singh
Kahol Atul Prakash
Khanuja Suman Preet Singh
Singh Tarun
Council of Scientific and Industrial Research
Feehery, Esq. Maryellen
Kumar, Esq. Natida P.B.A.
Reed Smith LLP
Solola Taofiq
LandOfFree
Single pot conversion of artemisinin to artesunic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Single pot conversion of artemisinin to artesunic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single pot conversion of artemisinin to artesunic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3247523